The AMPK-activated protein kinase (AMPK) is a regulator of energy balance at both the single-cell and whole-body levels (Kahn et al., 2005) and a target for drugs aimed at treatment of type 2 diabetes and the metabolic syndrome (Hardie, 2007a). The gene discussed is PRKAA2; the disease is metabolic syndrome.